Biomedical catalyst 2017 round 3: early stage
Micro, small or medium-size UK companies can apply for a share of £10 million to work alone or with others on solving healthcare challenges.
The aim of this competition is to support the development of technologies and processes including:
- disease prevention and proactive management of health and chronic conditions
- earlier and better detection and diagnosis of disease, leading to better patient outcomes
- tailored treatments that either change the underlying disease or offer potential cures
The biomedical catalyst has 4 types of funding award designed to support small to medium enterprises (SMEs) that are developing a product or process. It helps them progress from initial concept through to late-stage development.
Each type of award has a different scope and you should apply only if your project fits a specific competition scope.
This is an early-stage competition. They are looking to fund projects that enable SMEs to complete a data package sufficient to support the subsequent testing of their product or process in a clinical setting (or other relevant environment). The early-stage project can include:
- experimental evaluation (lab scale)
- use of in vitro and in vivo models (but not studies in humans or patients) to evaluate proof of concept and safety testing to appropriate regulatory standards
- exploration of potential production mechanisms
- early-stage prototyping
- product development planning
- intellectual property protection
Projects should last between one and 3 years and range between £250,000 and £4 million.
Find out more on the competition page here.